Drugs / Sm-EDTMP
last change Jun 2017 re-read 3 minutes ago

Sm-EDTMP

Developed for
osteosarcoma
Investigated by
Jazz Pharmaceuticals · National Cancer Institute (NCI) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01886105 Aug 2013 → Dec 2015 osteosarcoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sm-EDTMP ClinicalTrials.gov intervention name — accepted as the source's own label NCT01886105 ↗